title: Third-degree heart block developing in a female patient with HLA-B27 positive ankylosing spondylitis.
authors.forename: Vasfi
authors.initials: V
authors.lastname: Ulusoy
authors.forename: Aşkin
authors.initials: A
authors.lastname: Ateş
authors.forename: Hülya
authors.initials: H
authors.lastname: Ciçekcioğlu
authors.forename: Yonca
authors.initials: Y
authors.lastname: Avcioğlu
authors.forename: Yaşar
authors.initials: Y
authors.lastname: Karaaslan
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D015796:HLA-B27 Antigen / Q000097:blood*; D006327:Heart Block / Q000150:complications* / Q000628:therapy; D006801:Humans; D010138:Pacemaker, Artificial; D013167:Spondylitis, Ankylosing / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D012460:Sulfasalazine / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D015796:HLA-B27 Antigen; D012460:Sulfasalazine